Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New Products In Brief

This article was originally published in The Gray Sheet

Executive Summary

Recent product approvals and launches

You may also be interested in...



Growth Ahead In Market For Vein-Viewing Technologies

Patient safety concerns and limited payments for hospital-acquired conditions (HACs) are fueling double-digit growth in the multibillion-dollar market for point-of-care vascular imaging devices as hospitals increasingly look to these vein-viewing technologies to improve patient satisfaction and minimize complications associated with venous access procedures.

People In Brief

Stryker names new president and CEO, and more news on industry personnel shifts.

Financings In Brief

InspireMD plans stock offering to raise up to $46 million for stent system. Torax gets $30 mil. for GERD treatment. BioFire Diagnostics raises $25 mil. for FilmArray platform. More financings.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031078

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel